PPARG and ASS1: Targets of Metabolic Alteration in Venetoclax / Decitabine Resistant Acute Myeloid Leukemia

被引：0
|
作者：
Yamatani, Kotoko [1 ]
Watanabe, Tatsuro [2 ]
Saito, Kaori [1 ]
Maiti, Abhishek [3 ]
Yamashita, Satoshi [4 ]
Khasawneh, Abdullah [1 ]
Paran, Faith Jessica [5 ]
Hayes, Kala [6 ]
Borthakur, Gautam [6 ]
Harman, Joe R. [7 ]
Kimura, Shinya [8 ]
DiNardo, Courtney D. [6 ]
Milne, Thomas A. [7 ]
Andreeff, Michael [9 ]
Tabe, Yoko [1 ,6 ]
Konopleva, Marina Y. [6 ,10 ,11 ]
机构：
[1] Juntendo Univ, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan
[2] Saga Univ, Dept Drug Discovery & Biomed Sci, Fac Med, Saga, Japan
[3] MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[4] Maebashi Inst Technol, Life Engn Dept, Fac Engn, Gunma, Japan
[5] Juntendo Univ, Grad Sch Med, Dept Res Support Utilizing Bioresource Bank, Tokyo, Japan
[6] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[7] Univ Oxford, MRC Weatherall Inst Mol Med, Radcliffe Dept Med, MRC Mol Haematol Unit, Oxford, England
[8] Saga Univ, Div Hematol Resp Med & Oncol, Dept Internal Med, Saga, Japan
[9] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX USA
[10] Montefiore Med Ctr, Dept Oncol, Bronx, NY USA
[11] Albert Einstein Coll Med, Bronx, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-178554
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Abbreviated venetoclax with decitabine or azacitidine in acute myeloid leukemia
    Bouligny, Ian M.
    Murray, Graeme
    Ho, Thuy
    Doyel, Michael
    Patel, Tilak
    Boron, Josh
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Alnimer, Yanal
    Zacholski, Kyle
    Venn, Chad
    Wages, Nolan A.
    Grant, Steven
    Maher, Keri R.
    LEUKEMIA RESEARCH, 2023, 134
  • [2] Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia
    Bouligny I.M.
    Murray G.
    Doyel M.
    Patel T.
    Boron J.
    Tran V.
    Gor J.
    Hang Y.
    Alnimer Y.
    Ho T.
    Zacholski K.
    Venn C.
    Wages N.A.
    Grant S.
    Maher K.R.
    Medical Oncology, 41 (3)
  • [3] Decitabine and venetoclax for IDH1/2-mutated acute myeloid leukemia
    Venugopal, Sangeetha
    Maiti, Abhishek
    DiNardo, Courtney D.
    Loghavi, Sanam
    Daver, Naval G.
    Kadia, Tapan M.
    Rausch, Caitlin R.
    Alvarado, Yesid
    Ohanian, Maro
    Sasaki, Koji
    Short, Nicholas J.
    Takahashi, Koichi
    Yilmaz, Musa
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Konopleva, Marina Y.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) : E154 - E157
  • [4] Venetoclax in combination with azacitidine or decitabine in relapsed/refractory acute myeloid leukemia
    Che, Yue
    Tan, Wanqing
    Liu, Ying
    Liu, Haitao
    Li, Lanlan
    Qin, Fangmei
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (01) : 209 - 214
  • [5] Prognostic Value of CRh in Acute Myeloid Leukemia Treated with Venetoclax and Decitabine
    Siddiqui, Maria
    Maiti, Abhishek
    Daver, Naval
    Kadia, Tapan
    Rausch, Caitlin
    Alvarado, Yesid
    Ohanian, Maro
    Sasaki, Koji
    Short, Nicholas
    Takahashi, Koichi
    Yilmaz, Musa
    Ravandi, Farhad
    Kantarjian, Hagop
    DiNardo, Courtney
    Konopleva, Marina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S303 - S304
  • [6] Evolution of Genomic Landscape in Acute Myeloid Leukemia after Decitabine and Venetoclax
    Maiti, Abhishek
    DiNardo, Courtney D.
    Daver, Naval
    Kadia, Tapan M.
    Borthakur, Gautam
    Short, Nicholas J.
    Pemmaraju, Naveen
    Ohanian, Maro
    Alvarado, Yesid
    Takahashi, Koichi
    Pierce, Sherry A.
    Patel, Keyur P.
    Jabbour, Elias J.
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Kantarjian, Hagop
    Konopleva, Marina
    BLOOD, 2021, 138
  • [7] Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclax
    Kim, Kunhwa
    Maiti, Abhishek
    Loghavi, Sanam
    Pourebrahim, Rasoul
    Kadia, Tapan M.
    Rausch, Caitlin R.
    Furudate, Ken
    Daver, Naval G.
    Alvarado, Yesid
    Ohanian, Maro
    Sasaki, Koji
    Short, Nicholas J.
    Takahashi, Koichi
    Yilmaz, Musa
    Tang, Guilin
    Ravandi, Farhad
    Kantarjian, Hagop M.
    DiNardo, Courtney D.
    Konopleva, Marina Y.
    CANCER, 2021, 127 (20) : 3772 - 3781
  • [8] Prognostic impact of conventional cytogenetics in acute myeloid leukemia treated with venetoclax and decitabine
    Venugopal, Sangeetha
    Maiti, Abhishek
    DiNardo, Courtney D.
    Qiao, Wei
    Ning, Jing
    Loghavi, Sanam
    Daver, Naval G.
    Kadia, Tapan M.
    Rausch, Caitlin R.
    Alvarado, Yesid
    Ohanian, Maro
    Sasaki, Koji
    Short, Nicholas J.
    Takahashi, Koichi
    Yilmaz, Musa
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Konopleva, Marina Y.
    LEUKEMIA & LYMPHOMA, 2021, 62 (14) : 3501 - 3505
  • [9] OPB-111077 in Combination with Decitabine and Venetoclax for the Treatment of Acute Myeloid Leukemia
    Wilde, Lindsay
    Martinez-Outschoorn, Ubaldo
    Palmisiano, Neil
    Kasner, Margaret
    BLOOD, 2019, 134
  • [10] Outcomes of TP53-Mutant Acute Myeloid Leukemia with Venetoclax and Decitabine
    Kim, Kunhwa
    Maiti, Abhishek
    Kadia, Tapan M.
    Ravandi, Farhad
    Daver, Naval
    Pemmaraju, Naveen
    Borthakur, Gautam
    Bose, Prithviraj
    Issa, Ghayas C.
    Short, Nicholas J.
    Yilmaz, Musa
    Alvarado, Yesid
    Ferrajoli, Alessandra
    Jabbour, Elias
    Jain, Nitin
    Ohanian, Maro
    Takahashi, Koichi
    Thompson, Philip A.
    Rausch, Caitlin R.
    Montalbano, Kathryn
    Pierce, Sherry A.
    Patel, Keyur P.
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    DiNardo, Courtney D.
    Konopleva, Marina
    BLOOD, 2020, 136
12345